Point-of-care testing can bring important diagnostic information directly to patients in their homes. For home health agencies operating in the United States, CLIA-waived POCT devices for home health agencies can support faster clinical decisions without requiring every patient to travel to a laboratory or clinic. But choosing a POCT device is not simply a matter of buying a small analyzer. Home health agencies need to consider CLIA requirements, intended use, specimen collection, analytical performance, quality control, operator training, connectivity, consumable costs, and the practical realities of testing in patients' homes. The FDA's current CLIA database lists numerous waived test systems, including blood glucose monitoring systems, urine testing systems, HbA1c analyzers, infectious disease tests, and other point-of-care technologies. Agencies should verify the current waiver status of the exact test system before purchasing. What Does CLIA-Waived Mean for Home Health Age...
A point-of-care bilirubinometer can provide rapid bilirubin measurements close to the patient, making it particularly useful in newborn care, maternity units, pediatric clinics, neonatal wards, and facilities where laboratory turnaround time may delay clinical decisions. For healthcare professionals, choosing the right device involves more than looking for the fastest result. Measurement principle, sample requirements, analytical performance, quality control, maintenance, and cost per test all matter. In neonatal care, rapid assessment of bilirubin is important because significant hyperbilirubinemia can lead to serious neurological complications if it is not recognized and managed appropriately. This makes bilirubin testing an important application of point-of-care testing, particularly where access to a central laboratory is limited. What Is a Point-of-Care Bilirubinometer? A bilirubinometer is an analytical device used to measure bilirubin concentration in a blood specimen. Depe...